Blockchain Registration Transaction Record

Tonix Pharmaceuticals to Present Real-World Fibromyalgia Data at ISPOR 2026

Tonix Pharmaceuticals presents real-world fibromyalgia data at ISPOR 2026 following TONMYA approval. Learn about TNXP's CNS and immunology pipeline.

Tonix Pharmaceuticals to Present Real-World Fibromyalgia Data at ISPOR 2026

This news matters because Tonix's TONMYA is the first new fibromyalgia treatment in over 15 years, offering hope to millions of patients who have had limited therapeutic options. Real-world data from this study could validate TONMYA's effectiveness in everyday clinical settings, potentially influencing prescribing practices and insurance coverage. For investors, positive data may boost confidence in Tonix's commercial strategy and pipeline, including its broader CNS and immunology programs.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x097089c8f34dd19cf98fbbaa5a87dd07f93c33a071b27f2cc1c9894b0dd6e169
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintfernNajs-27217f540828dd5f71f870df06472664